INHIBIGENS Trademark

Trademark Overview

On Friday, February 14, 2020, a trademark application was filed for INHIBIGENS with the United States Patent and Trademark Office. The USPTO has given the INHIBIGENS trademark a serial number of 88797352. The federal status of this trademark filing is REGISTERED as of Tuesday, June 22, 2021. This trademark is owned by Genocea Biosciences, Inc.. The INHIBIGENS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

medical treatment of cancer, infectious diseases, immune system-related diseases and disorders, and pathogen-induced diseases and disorders, namely, immunotherapies; antigen-directed cell therapy services
inhibigens

General Information

Serial Number88797352
Word MarkINHIBIGENS
Filing DateFriday, February 14, 2020
Status700 - REGISTERED
Status DateTuesday, June 22, 2021
Registration Number6398491
Registration DateTuesday, June 22, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesmedical treatment of cancer, infectious diseases, immune system-related diseases and disorders, and pathogen-induced diseases and disorders, namely, immunotherapies; antigen-directed cell therapy services

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 13, 2020
Primary Code044
First Use Anywhere DateTuesday, May 12, 2020
First Use In Commerce DateTuesday, May 12, 2020

Trademark Owner History

Party NameICHOR MEDICAL SYSTEMS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121
Party NameGenocea Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameGenocea Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events

Event DateEvent Description
Wednesday, January 4, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 22, 2021REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, May 18, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 18, 2021ASSIGNED TO LIE
Tuesday, May 18, 2021NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, May 17, 2021APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Monday, May 17, 2021USE AMENDMENT ACCEPTED
Saturday, May 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 14, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 14, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, May 15, 2021AMENDMENT TO USE PROCESSING COMPLETE
Saturday, May 15, 2021USE AMENDMENT FILED
Friday, May 14, 2021TEAS AMENDMENT OF USE RECEIVED
Monday, November 16, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 16, 2020FINAL REFUSAL E-MAILED
Monday, November 16, 2020FINAL REFUSAL WRITTEN
Friday, November 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 13, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 13, 2020NON-FINAL ACTION E-MAILED
Wednesday, May 13, 2020NON-FINAL ACTION WRITTEN
Wednesday, May 6, 2020ASSIGNED TO EXAMINER
Thursday, February 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 18, 2020NEW APPLICATION ENTERED

Related Keywords

inhibigens diseases disorders antigen immunotherapies namely directed cell services therapy induced